Evidence map›Paper›PMID 42164869›Full record

ArticleBiofilm2026

Model-dependent efficacy of sequential phage-antibiotic-antifungal therapy against dual-species biofilms.

Marta Gliźniewicz, Barbara Dołęgowska, Kamila Dubrowska, Joanna Honselmann Genannt Humme, Marcin Gawęda, Bartłomiej Grygorcewicz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biofilm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta GliźniewiczDepartment of Laboratory Medicine, Chair of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, Szczecin, 70-111, Poland.
Barbara DołęgowskaDepartment of Laboratory Medicine, Chair of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, Szczecin, 70-111, Poland.
Kamila DubrowskaDepartment of Chemical and Process Engineering, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Piastów Avenue 42, Szczecin, 71-065, Poland.
Joanna Honselmann Genannt HummeDepartment of Chemical and Process Engineering, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Piastów Avenue 42, Szczecin, 71-065, Poland.
Marcin GawędaDepartment of Aesthetic Dentistry, Medical Center of the Medical University of Warsaw, Jana Nielubowicza 5, Warszawa, 02-097, Poland.
Bartłomiej GrygorcewiczDepartment of Genomics and Forensic Genetics, Faculty of Medicine, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, Szczecin, 70-111, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising rate of antimicrobial resistance presents a major global health risk.

Indexed as

Dual-species biofilmGalleria mellonellaHuman bloodHuman urineSequential phage-antibiotic-antifungal therapy

Identifiers

PMID42164869
PMCPMC13185768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.